Why the study?
Does double heterozygosity for factor V R506Q and protein C T298M mutations increase the risk of venous thromboembolism compared to single or no mutations in a family with hereditary thrombophilia?
Does double heterozygosity for factor V R506Q and protein C T298M mutations increase the risk of venous thromboembolism compared to single or no mutations in a family with hereditary thrombophilia?
The coexistence of heterozygous protein C deficiency and factor V Leiden mutation significantly increases the risk of venous thromboembolism, supporting the multigenic nature of hereditary thrombophilia.
No takes yet. Share an insight, caveat, or question.
Double heterozygosity was associated with VTE in this family; supports multigenic thrombophilia but leaves generalizability open.
Brenner et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: